12063 related articles for article (PubMed ID: 10861442)
1. The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors.
Hartmann JT; Nichols CR; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Einhorn L; Kanz L; Bokemeyer C
Cancer; 2000 Jun; 88(11):2629-35. PubMed ID: 10861442
[TBL] [Abstract][Full Text] [Related]
2. Disease characteristics and survival outcomes of extragonadal primary germ cell tumour in two Canadian tertiary cancer centres.
Ko JJ; Asif T; Li H; Alimohamed N; Nguyen PT; Heng DY
Can Urol Assoc J; 2016; 10(5-6):E165-E170. PubMed ID: 27790297
[TBL] [Abstract][Full Text] [Related]
3. DNA damage levels in peripheral blood mononuclear cells before and after first cycle of chemotherapy have comparable prognostic values in germ cell tumor patients.
Ivovič D; Šestáková Z; Roška J; Kálavská K; Hurbanová L; Holíčková A; Smolková B; Kabelíková P; Novotná V; Chovanec M; Palacka P; Mego M; Jurkovičová D; Chovanec M
Front Oncol; 2024; 14():1360678. PubMed ID: 38496757
[TBL] [Abstract][Full Text] [Related]
4. Prophylaxis Against Thromboembolic Events During Chemotherapy for Germ Cell Cancer.
Meng X; Ahmed M; Courtney KD; Arafat W; Ibrahim I; Margulis V; Nichols C; Bagrodia A
Front Oncol; 2021; 11():724682. PubMed ID: 34692501
[TBL] [Abstract][Full Text] [Related]
5. Extragonadal Germ Cell Tumor with Hepatic Infiltration in a Child: Aberrant Somatostatin Receptors and the Diagnostic Conundrum.
Peters NJ; Behera S; Gupta P; Jain R; Singh H; Madan R; Mahajan JK
J Indian Assoc Pediatr Surg; 2024; 29(2):162-164. PubMed ID: 38616838
[TBL] [Abstract][Full Text] [Related]
6. Testicular microlithiasis, chemotherapy for stage I seminoma, and chemotherapy for advanced extragonadal germ cell tumors.
Han KR; Wieder JA; Bui MH; Belldegrun AS
Rev Urol; 2002; 4(4):200-2. PubMed ID: 16985684
[No Abstract] [Full Text] [Related]
7. Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential.
Turpeenniemi-Hujanen T; Thorgeirsson UP; Hart IR; Grant SS; Liotta LA
J Natl Cancer Inst; 1985 Jul; 75(1):99-103. PubMed ID: 2989606
[TBL] [Abstract][Full Text] [Related]
8. Action on various experimental tumour-host systems of methyoxy-substituted glycerol ethers incorporated into the feed.
Boeryd B; Hallgren B
Acta Pathol Microbiol Scand A; 1980 Jan; 88(1):11-8. PubMed ID: 7376873
[TBL] [Abstract][Full Text] [Related]
9. [Expression of tumor metastasis suppressor gene KAI1/CD82 in human cancer cell lines with different metastasis potential].
Li S; Fang W; Zhong H
Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):708-10. PubMed ID: 11715465
[TBL] [Abstract][Full Text] [Related]
10. T cells migrate to tumour sites after extracorporeal interleukin 2 stimulation and reinfusion in a patient with metastatic melanoma.
Dummer R; Becker JC; Eilles C; Schäfer E; Börner W; Burg G
Br J Dermatol; 1993 Apr; 128(4):399-403. PubMed ID: 8494752
[TBL] [Abstract][Full Text] [Related]
11. [Morphologic features and biological properties of melanomas in children].
Parshikova SM; Filippova NA; Bogatyreva II
Arkh Patol; 1986; 48(6):60-7. PubMed ID: 3753240
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for experimental brain tumors using a xenogenic cell line engineered to secrete hIL-2.
Lesniak MS; Tyler BM; Pardoll DM; Brem H
J Neurooncol; 2003; 64(1-2):155-60. PubMed ID: 12952296
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment with radiation and hyperthermia in metastatic malignant melanoma.
Gonzalez Gonzalez D; van Dijk JD; Blank LE; Rümke P
Radiother Oncol; 1986 Jun; 6(2):105-13. PubMed ID: 3737980
[TBL] [Abstract][Full Text] [Related]
14. Glycosaminoglycans of BALB/c 3T3 and B16.F10 melanoma cells. Metabolic differences.
Piepkorn M; Hovingh P; Linker A
Lab Invest; 1987 Sep; 57(3):306-10. PubMed ID: 3626520
[TBL] [Abstract][Full Text] [Related]
15. Tumor imaging with carbon-11 labeled alpha-aminoisobutyric acid (AIB) in patients with malignant melanoma.
Sordillo PP; DiResta GR; Fissekis J; Conti P; Benua RS; Yeh SD; Laughlin JS
Am J Physiol Imaging; 1991; 6(4):172-5. PubMed ID: 1817569
[TBL] [Abstract][Full Text] [Related]
16. Expression of tissue-type transglutaminase correlates positively with metastatic properties of human melanoma cell lines.
van Groningen JJ; Klink SL; Bloemers HP; Swart GW
Int J Cancer; 1995 Jan; 60(3):383-7. PubMed ID: 7829248
[TBL] [Abstract][Full Text] [Related]
17. 31P NMR spectroscopy studies of phospholipid metabolism in human melanoma xenograft lines differing in rate of tumour cell proliferation.
Lyng H; Olsen DR; Petersen SB; Rofstad EK
NMR Biomed; 1995 Apr; 8(2):65-71. PubMed ID: 7547188
[TBL] [Abstract][Full Text] [Related]
18. Metastatic potential of metastases, tumor cell heterogeneity, and therapeutic implications.
Spreafico F; Mantovani A; Giavazzi R; Conti G; Anaclerio A
Recent Results Cancer Res; 1982; 80():1-8. PubMed ID: 7058275
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. I. Determination of the selectivity of six antibodies by cell ELISA and immunofluorescence.
Koho H; Paulie S; Ben-Aissa H; Jónsdóttir I; Hansson Y; Lundblad ML; Perlmann P
Cancer Immunol Immunother; 1984; 17(3):165-72. PubMed ID: 6383600
[TBL] [Abstract][Full Text] [Related]
20. Melanosome and lysosome. II. Digestion of melanosome with mouse liver lysosome.
Otaki N
Bull Tokyo Med Dent Univ; 1970 Sep; 17(3):179-86. PubMed ID: 5273194
[No Abstract] [Full Text] [Related]
[Next] [New Search]
